FIRM FIXED PRICENO SET ASIDE USED.
TIBA BIOTECH LLC - TIBA BIOTECH, LLC - AOI#25(FASTX) R&D FOR RESPIRATORY VIRUS TREATMENT USING LUNG-TARGETED SIRNA DELIVERY
PIID: 75A50124C00014Solicitation ID: BAA-22-100-SOL-00003
Signed Date: Nov 14, 2025Effective Date: Apr 30, 2024End Date: Closed on Aug 5, 2025
Key Details
Description
TIBA BIOTECH, LLC - AOI#25(FASTX) R&D FOR RESPIRATORY VIRUS TREATMENT USING LUNG-TARGETED SIRNA DELIVERY
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.